Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: a pilot study (Q33499749)

27 July 2017

title

Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: a pilot study (English)

1 reference

non-small-cell lung carcinoma

27 July 2017

1 reference

1 reference

1 reference

1 reference

Lau DH

1

1 reference

27 July 2017

Ryu JK

series ordinal

2

1 reference

27 July 2017

Gandara DR

series ordinal

3

1 reference

27 July 2017

Rosenthal SA

series ordinal

4

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

International Journal of Radiation Oncology Biology Physics

27 July 2017

published in

1 reference

27 July 2017

volume

38

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

157-161

1 reference

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

A new international staging system for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

Combined modality therapy for locally advanced non-small cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900249-6

7 January 2021

10.1016/S0360-3016(97)00249-6

Identifiers

DOI

1 reference

27 July 2017

1 reference